- Home
- SDA vs LAB Comparison
SDA vs LAB Comparison
Compare SDA & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDA
- LAB
- Stock Information
- Founded
- SDA 2007
- LAB 1999
- Country
- SDA China
- LAB United States
- Employees
- SDA N/A
- LAB 818
- Industry
- SDA Blank Checks
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- SDA Finance
- LAB Industrials
- Exchange
- SDA Nasdaq
- LAB Nasdaq
- Market Cap
- SDA 548.5M
- LAB 451.0M
- IPO Year
- SDA N/A
- LAB 2011
- Fundamental
- Price
- SDA $2.86
- LAB $1.16
- Analyst Decision
- SDA
- LAB Buy
- Analyst Count
- SDA 0
- LAB 2
- Target Price
- SDA N/A
- LAB $2.50
- AVG Volume (30 Days)
- SDA 185.4K
- LAB 1.2M
- Earning Date
- SDA 04-28-2025
- LAB 05-06-2025
- Dividend Yield
- SDA N/A
- LAB N/A
- EPS Growth
- SDA N/A
- LAB N/A
- EPS
- SDA N/A
- LAB N/A
- Revenue
- SDA $425,992,000.00
- LAB $174,432,000.00
- Revenue This Year
- SDA $63,167.77
- LAB N/A
- Revenue Next Year
- SDA N/A
- LAB $12.77
- P/E Ratio
- SDA N/A
- LAB N/A
- Revenue Growth
- SDA 29.36
- LAB 64.03
- 52 Week Low
- SDA $2.41
- LAB $0.97
- 52 Week High
- SDA $11.74
- LAB $2.74
- Technical
- Relative Strength Index (RSI)
- SDA 29.32
- LAB 48.92
- Support Level
- SDA $2.61
- LAB $0.99
- Resistance Level
- SDA $2.98
- LAB $1.33
- Average True Range (ATR)
- SDA 0.41
- LAB 0.09
- MACD
- SDA 0.07
- LAB 0.01
- Stochastic Oscillator
- SDA 38.66
- LAB 52.78
About SDA SunCar Technology Group Inc.
SunCar Technology Group Inc is a provider of digitalized enterprise automotive after-sales services and online auto insurance intermediation service in China. It operates an automotive after-sales services business through offering customized service solutions to enterprise clients, who are major banks, insurance companies, telecommunication companies, new energy vehicle, original equipment manufacturers or any client who have end customers demanding automotive services.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.